Cite
RPP30 is a novel diagnostic and prognostic biomarker for gastric cancer.
MLA
Ying Kan, et al. “RPP30 Is a Novel Diagnostic and Prognostic Biomarker for Gastric Cancer.” Frontiers in Genetics, vol. 13, July 2022, pp. 1–10. EBSCOhost, https://doi.org/10.3389/fgene.2022.888051.
APA
Ying Kan, Xia Lu, Lijuan Feng, Xu Yang, Huan Ma, Jianhua Gong, & Jigang Yang. (2022). RPP30 is a novel diagnostic and prognostic biomarker for gastric cancer. Frontiers in Genetics, 13, 1–10. https://doi.org/10.3389/fgene.2022.888051
Chicago
Ying Kan, Xia Lu, Lijuan Feng, Xu Yang, Huan Ma, Jianhua Gong, and Jigang Yang. 2022. “RPP30 Is a Novel Diagnostic and Prognostic Biomarker for Gastric Cancer.” Frontiers in Genetics 13 (July): 1–10. doi:10.3389/fgene.2022.888051.